Article
In vitro and in vivo inhibition of neuroblastoma tumor cell growth by AKT inhibitor perifosine.
Journal of the National Cancer Institute - 2 Jun 2010
Li Zhijie, Tan Fei, Liewehr David J, Steinberg Seth M, Thiele Carol J
Abstract excerpt
BACKGROUND: Activated AKT is a marker of decreased event-free or overall survival in neuroblastoma (NB) patients. The aim of this study was to investigate the effect of perifosine, a nontoxic AKT inhibitor, as a single agent on NB cell growth in vitro and in vivo. METHODS: Four human NB cell lines (AS, NGP, BE2, and KCNR) were treated with increasing concentrations of perifosine, and a quantitative analysis of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
